3ZG-81407-91532
3 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 601 / IL
- Registered
- 2021-06-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-28
Dose 1 — Pfizer-BioNTech
-
2021-06-29
Registered in v-safe
- 2021-06-29
- 2021-06-30
- 2021-07-01
- 2021-07-04
- 2021-07-12
-
2021-07-19
Dose 2 — Pfizer-BioNTech
- 2021-07-19
-
2021-07-20
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2021-07-22
- 2021-07-23
- 2021-07-25
- 2021-07-26
- 2021-08-02
- 2021-08-09
- 2021-08-16
- 2021-08-23
- 2021-08-30
- 2021-10-18
- 2022-01-19
-
2022-02-03
Dose 3 — Pfizer-BioNTech
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-28 | Pfizer-BioNTech | No |
| 2 | 2021-07-19 | Pfizer-BioNTech | No |
| 3 | 2022-02-03 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release